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Abstract
Background: The immune system gradually deteriorates with age and nutritional status is a major factor in
immunosenescence. Of the many nutritional factors implicated in age-related immune dysfunction, vitamin A may
be a good candidate, since vitamin A concentrations classically decrease during aging whereas it may possess
important immunomodulatory properties via its active metabolites, the retinoic acids. This prompted us to
investigate the immune response induced by retinoids in adults and elderly healthy subjects. Before and after oral
supplementation with 13cis retinoic acid (0.5 mg/kg/day during 28 days), whole blood cells were phenotyped, and
functions of peripheral blood mononuclear cells (PBMC) and polymorphonuclear cells (PMN) were investigated by
flow cytometry and ELISA tests.
Results: In both young adults (n = 20, 25 ± 4 years) and older subjects (n = 20, 65 ± 4 years), retinoic acid
supplementation had no effect on the distribution of leukocyte subpopulations or on the functions of PBMC (Il-2
and sIl-2R production, membrane expression of CD25). Concerning PMN, retinoic acid induced an increase in both
spontaneous migration and cell surface expression of CD11b in the two different age populations, whereas
bactericidal activity and phagocytosis remained unchanged.
Conclusions: We demonstrated that retinoic acid induces the same intensity of immune response between adult
and older subjects, and more specifically affects PMN functions, i.e. adhesion and migration, than PBMC functions.
Background
Efficacy of the immune system deteriorates with increasing
age. This immunosenescence affects both the innate and
the adaptive pathways immune pathways. The decline in
the adaptive immune response has been well documented
[1], highlighting an alteration in humoral immunity [2]
and defective B and T-cell production [3]. Innate immu-
nity is mediated by a diverse group of cell types and
mechanisms, including monocytes/macrophages, natural
killer (NK) cells, dendritic cells, neutrophils (PMNs), eosi-
nophils and basophils, and by the elaboration of cytokines.
Given that PMNs are the largest fraction of white blood
cells and the first line of defense against pathogens, the lit-
erature contains numerous but inconsistent findings on
the effect of aging on PMN numbers and functions (adhe-
sion, chemotaxis, phagocytosis, radical oxygen species
(ROS) production) (see review [4-7]) (table 1) [8-26].
These conflicting data may result from difficulties in
distinguishing age-dependent specific changes in the
immune system. Many other factors such as chronic dis-
ease, nutrition, and lifestyle have a profound effect on
immunity, and could thus participate in more subtle age-
related changes [27]. This immunosenescence is one rea-
son older adults in general are vulnerable to infection and
may play a central role in many degenerative diseases, yet
the mechanisms are unclear. Consequently, understanding
these immune dysfunctions is becoming increasingly
important as the average life expectancies reach record
levels.
Vitamin A (retinol) is known to play an essential role
in the immune system and may be important for the
optimal functioning of the innate and adaptive immune
system [28]. Vitamin A deficiency is associated with exa-
cerbated immunodeficiency [29], reduced or unbalanced
lymphocyte counts [30], and deregulated antibody pro-
duction [31]. Moreover, vitamin A supplementation
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dren in areas where vitamin A deficiency is endemic
[32]. These immunomodulatory properties have been
demonstrated in both animal and humans studies
[33,34], with somewhat contradictory results. The
underlying cellular and molecular mechanisms govern-
ing the effect of vitamin A on the immune system
remain elusive [35] but are primarily mediated via its
acid derivatives, including all-trans-, 13-cis and 9-cis-
retinoic acids [36]. The physiological effects of retinoids
are mediated by members of two families of nuclear
receptors: the RARa,R A R b and RARg isotypes, and the
RXRa,R X R b and RXRg isotypes. RARs bind both all-
trans and 9-cis RA, whereas only 9-cis RA stereoisomers
bind to RXRs.
Age-related alterations in vitamin A metabolism, parti-
cularly plasma retinol concentrations, have been
reported in rats and humans [37,38] but also extend to
retinoid receptors. Indeed, while retinoic acid receptor
subtype expression in human PBMC follows the same
distribution pattern in adult and old subjects, RXRb
expression is decreased in elderly subjects whereas
RARa expression remains age-stable: RXRb (39.8% in
young men; 31.6% in elderly men) > RARg (32.3%
in young men; 33.4% in elderly men) > RXRa (17.8% in
young men; 22.3% in elderly men) > RARa (10.3% in
young men; 12.5% in elderly men) [39,40]
Nutritional status is a major factor in immunosenes-
cence, and we have demonstrated that immunological
adaptations to nutritional changes differ according to
subject age [27]. Of the many nutritional factors impli-
cated in age-related immune dysfunction, vitamin A
may be a good candidate, firstly since vitamin A concen-
trations may be altered during aging, and secondly since
vitamin A may possess important immunomodulatory
properties. Reports on plasma vitamin A levels in free-
living elderly populations are inconsistent, with some
authors reporting a decrease whereas others describe no
effect of aging on vitamin A [41-49]. These conflicting
data may stem from the use of rather small or highly
selective samples of older persons. However a recent
study performed in a large sample of elderly subjects
[50] confirmed that a non-negligible proportion of this
population might be at risk of inadequate vitamin A
status.
This prompted us to investigate the immune response
induced by retinoids in adults and elderly healthy sub-
jects. Since metabolism of vitamin A may be altered
during aging, we investigated the biological actions of its
active metabolite, i.e. retinoic acid, on immunocompe-
tent cells. An oral 13-cis-retinoic acid supplementation
was given to two groups aged 20-35 years and 60-75
years, and immune modulation was evaluated by pheno-
typic and functional assessment of blood leukocytes. In
this cohort, we first measured retinoic acid receptor
expression and demonstrated that RXRb mRNA in
PBMC was downregulated in elderly males but was
upregulated after supplementation with 13-cis retinoic
acid [40]. Thus, in light of this finding, this second part
of our study (performed in the same cohort) was
designed to investigate how these RXRb expression
modifications induced by retinoic acid translate biologi-
cally in terms of immune response in elderly subjects.
Methods
Subjects and treatment
Healthy male subjects (n =4 0 )w e r er e c r u i t e df r o mt h e
Clermont-Ferrand area (France). Volunteers underwent
Table 1 Effects of aging on neutrophil numbers and functions
NO EFFECT DECREASE
NUMBER Chatta G. S., 1993, Gerontology
Born J., 1995, Mech. Ageing Dev.
Chatta G.S., 1996, Drugs Aging
De Martinis M., 2004, Immunol. Cell. Biol.
ADHESION MacGregor R. R., 1990, J. Gerontol.
Tortorella C, 1993, Mech. Ageing Dev.
Esparza B., 1996, Immunol. Investig.
Biasi D., 1996, Inflammation
Damtew B., 1990, Clin. Immunol. Immunopathol.
De Martinis M., 2004, Immunol. Cell. Biol.
CHEMOTAXIS Corberand J., 1981, J. Am. Geriatr. Soc
Phair J. P., 1978, J. Infect. Dis.
MacGregor R. R., 1990, J. Gerontol.
Esparza B., 1996, Immunol. Invest.
Alonso-Fernandez P., 2008, J. Am. Geriatr. Soc.
Niwa Y., 1989, Life Sci.
Polignano A., 1994, Cytobios
Wenisch C., 2000, J. Leukoc. Biol.
Isgüt-Uysal V.N, 2003, Mech. Ageing Dev.
PHAGOCYTOSIS Niwa Y., 1989, Life Sci.
Chan S.S., 1998, Free Radic. Biol. Med.
Mege J.L., 1988. Neurobiol. Ageing
Butcher S. K., 2001, J. Leukoc. Biol.
Lord J.M. et al., 2001, Mech. Ageing Dev.
Isgüt-Uysal V.N., 2003, Mech. Ageing Dev.
Göcer P., 2005, Med. Princ. Prat.
ROS PRODUCTION Wenisch C., 2000, J. Leukoc. Biol.
Göcer P., 2005, Med. Princ. Pract.
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Page 2 of 11a screening procedure that included medical history,
physical examination, routine urine analysis and blood
clinical chemistry profile. The study enrolled volunteers
without malabsorption problems, liver disease, diabetes
or hyperlipemia, who were not using steroids or other
immunosensitive drugs, and who had not used vitamin
supplements in the previous 30 days. The subjects were
non-smokers and ingested alcohol no more than occa-
sionally. The study was approved by the local ethical
committee, and written informed consent was obtained
from each subject before participation in the study. To
assess the age effect, participants were picked from two
age brackets: 20-35 years (mean: 25 ± 4 yrs) and 60-75
years (mean: 65 ± 4 yrs). The older subjects met medical
criteria comparable to those specified by the SENIEUR
protocol [51] for investigations into aging and the
immune system. After examination by a dermatologist,
the volunteers took 0.5 mg/kg b.w./day of 13-cis-retinoic
acid (Curacné®, Pierre Fabre) for 28 days. All the volun-
teers were asked to avoid vitamin A-rich foods (mainly
liver) and keep exposure to sunlight to a minimum, and
were regularly contacted by the medical staff to note
side effects.
Venous blood sampling
Venous peripheral blood samples (10 ml) were collected
into vacutainer tubes containing EDTA before (T0)a n d
after the retinoid supplementation period (T1). Part
(4 ml) of the total blood was used for the determination
of ROS production by PMN cells and for blood leuko-
cyte phenotyping. The rest (6 ml) was used to isolate
both PMNs and PBMC for functional analysis.
At both time-points (T0 and T1), another venous per-
ipheral blood sample (5 ml) was collected without antic-
oagulant, and centrifuged before isolation of sera. Sera
were aliquoted and stored at -80°C for analysis of
immune parameters.
Plasma retinoic acid concentrations
13-cis-retinoic acid and retinol were assayed using a
validated HPLC method as described by Wyss and
Bucheli [52].
Determination of serum immune parameters
Serum immunoglobulin (IgG, IgA, IgM) and comple-
ment fraction (C3, C4) concentrations were quantified
by immunonephelemetry (array protein system, Beck-
man Coulter, Villepinte, France) using human antibodies
(Beckman Coulter). Values are expressed in g/L. Serum
soluble interleukin-2 receptor (sIl-2R) levels (expressed
in pmol/L) were measured by ELISA (Immunotech kit,
Beckman Coulter). The accuracy of our determinations
is assured by a quality control scheme (VIGIL, Beckman
Coulter, Villepinte).
Count and phenotype of blood leukocytes
Lymphocyte subpopulations were determined by flow
cytometry (Epics XL, Beckman Coulter) using a large
panel of fluorochrome conjugated monoclonal antibo-
dies (Beckman Coulter). A simple staining technique
w a su s e dt oi d e n t i f ym a t u r eTc e l l s( C D 3 - P C 5 ) ,Bl y m -
phocytes (CD19-ECD) and natural killer (NK) cells
(CD56-PE). Dual-staining techniques were used to iden-
tify ‘memory’ (CD4-RD1/CD45RO-FITC) and ‘naive’
(CD4-RD1/CD45RA-FITC) populations of CD4+ cells.
Triple-staining techniques were used to identify
T-helper/inducer cells (CD3-PC5/CD4-RD1) and T-sup-
pressor cells (CD3-PC5/CD8-ECD). To explore the
expression of lymphocyte activation markers, whole
blood cells were stained with anti-CD69 and anti-HLA-
DR. In practice, peripheral venous blood samples were
incubated with saturating concentrations of antibodies,
and then depleted of red blood cells and fixed using the
immunoprep reagent system (Beckman-Coulter). After
addition of flow count spheres (Beckman Coulter), sam-
ples were finally analyzed by flow cytometry. Results are
expressed in percentage of total lymphocyte population
and in absolute values.
PMN receptors expression was determined by flow
cytometry using fluorochrome-conjugated monoclonal
antibodies (Beckman Coulter). The panel of monoclonal
antibodies used was FITC anti-CD11b, FITC anti-CD18
and FITC anti-CD62L. Results are expressed in percen-
tage of total PMN cell population and in absolute
values. The fluorescence intensity of CD11b, expressed
in arbitrary units (AU), is a qualitative reflection of the
number of CD11b subset present on the PMN cell
surface.
The results of our participation in the interlaboratory
quality assurance programme (Immunotrol, Beckman
Coulter) indicate the accuracy of the blood leukocyte
phenotypes.
Determination of blood leukocyte functions
Immune cells were isolated from whole blood on a dis-
continuous Ficoll-Hypaque density gradient (Histopaque
1077 and 1119, Sigma, Saint-Quentin-Fallavier, France).
Isolated mononuclear cells and PMN were tested for
purity (> 95%) and viability (> 95%) by flow cytometry.
In vitro determination of Il-2 and its two receptors (sIl-
2R and CD25): A mononuclear cell suspension (10
6
cells/ml) was incubated with and without phytohemag-
glutinin (5 μg/ml) (PHA from Phaseolus vulgaris,
Sigma). After 48 h and 96 h of incubation, the cell-free
supernatant of the culture medium was harvested and
frozen at -80°C until analysis of Il-2 and its soluble
receptor (sIl-2R) by ELISA tests (Beckman Coulter).
Results are expressed in fmol/10
6cells. For CD25 expres-
sion, cells were incubated with FITC antiCD25
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spheres (Beckman Coulter). Results are expressed as
percentage of cells expressing CD25 and number of
CD25 per cell.
PMN cell chemotaxis
PMN chemotaxis was determined by agarose assay
(Indubiose A37, Biosepra, France) using formyl-methio-
nyl-leucyl-phenylananine (fMLP, 10
-7 M) as chemotactic
factor for 90 min (37°C, 5% CO2). Cell migration dis-
tances (in mm) were then measured microscopically in
the direction of the chemoattractant (directed migra-
tion) and towards the control (spontaneous migration).
Neutrophils chemotaxis index is expressed as the ratio
of directed to spontaneous migration of PMN cells.
PMN hydrogen peroxide (H2O2) production
PMN H2O2 production was quantified by flow cytometry
(Beckman Coulter) as described in [53]. Briefly, white
blood cells (10
6 cells/ml) were stimulated with phorbol
myristate acetate (PMA, 10
-8 M) or opsonized zymosan
(10 mg/ml). H2O2 production was then evaluated by the
fluorescence intensity of an intracellular oxidized probe
(dihydrorhodamine 123). Results are expressed in AU.
Statistics
Results are expressed as means ± SEM. All statistical
analyses were run on Statview SAS, version 5. The
experimental design comprised two cross-fixed factors
with the factor ‘aging’ as two classes (adults and elderly)
and the factor ‘nutritional treatment’ as two classes (T0:
basal state, T1: retinoic acid supplemented). This design
allowed statistical analysis by two-way repeated-mea-
sures analysis of variance (ANOVA) in order to discri-
minate between the effects of aging (A), nutritional
treatment (N), and their interaction (I). The level of sig-
nificance was set at p < 0.05 for this test. When the
ANOVA indicated significant interactions, the Newman-
Keüls test was used to identify differences between indi-
vidual means. When no significant interaction was
found, the Newman-Keüls test was used to calculate
and compare the marginal means.
Results
Clinical and biological features of the volunteers
Clinical examination showedt h a tn o n eo ft h e4 0v o l u n -
teers presented any severe side effects. Most of the volun-
teers had only noticed expected skin dryness. Retinoic acid
supplementation and aging did not significantly affect cho-
lesterolemia (adults T0: 5.28 ± 0.66 mM, T1:5 . 6 1±1 . 0 2
mM; elderly T0: 6.99 ± 1.09 mM, T1: 7.16 ± 1.73 mM) or
triglyceridemia (adults T0: 1.02 ± 0.30 mM, T1: 1.11 ± 0.27
mM; elderly T0: 1.02 ± 0.25 mM, T1: 1.26 ± 0.49 mM).
Plasma retinoic acid and retinol concentrations
Plasma 13-cis-retinoic acid concentrations were signifi-
cantly affected by aging, supplementation and their
interaction: they were increased at T1 in young adults
and in elderly subjects and were significantly lower in
older supplemented subjects than young adults (table 2).
There was no difference in baseline plasma 13-cis-reti-
noic acid concentrations between young and older adults.
Plasma retinol concentrations were higher in the older
subjects than the young adults but were not altered by
retinoic acid supplementation (table 2).
Serum immune parameters
Concentrations of IgA, IgG, IgM, C3, C4 and rIL2 s were
not altered by age or by retinoic acid supplementation (IgG
(g/L): adults T0: 12.30 ± 0.70, T1: 12.37 ± 0.60; elderly T0:
12.47 ± 0.65, T1: 12.57 ± 0.62; IgA (g/L): adults T0: 2.64 ±
0.30, T1: 2.25 ± 0.23; elderly T0: 3.09 ± 0.28, T1:2 . 8 5±
0.28; IgM (g/L): adults T0: 1.47 ± 0.13, T1: 1.43 ± 0.14;
elderly T0: 1.43 ± 0.13, T1: 1.60 ± 0.30; C3 (g/L): adults T0:
1.03 ± 0.07, T1:1 . 0 9±0 . 0 4 ;e l d e r l yT0:1 . 1 4±0 . 0 5 ,T1:1 . 1 7
± 0.05; C4 (g/L): adults T0: 0.25 ± 0.02, T1: 0.25 ± 0.02;
elderly T0: 0.30 ± 0.02, T1: 0.31 ± 0.02; rIl2 s (fM): adults
T0:2 2±3 ,T1: 23 ± 14; elderly T0:2 4±4 ,T1:2 9±7 ) .
White blood cell count
The leukocyte population, which includes lymphocytes,
monocytes, and neutrophils was not altered by age or by
retinoic acid supplementation (data not shown).
Phenotypes and counts of blood leukocyte
subpopulations
Lymphocytes
T lymphocytes expressed as a percentage or in absolute
numbers were not modified by age or retinoic acid sup-
plementation (Table 3). Age was associated with a lower
absolute number of B lymphocytes without significant
change in the proportion of this cell population. Reti-
noic acid supplementation induced no alteration in
absolute number or percentage of B lymphocytes. NK
lymphocytes were proportionally higher in elderly sub-
jects than young adults but there was no effect of nutri-
tional treatment. Absolute numbers of NK cells were
not modified by aging or retinoic acid supplementation.
Neither the proportion (data not shown) nor absolute
number(in 10
9/L) of CD4
+ or CD8
+ cells was modified
by aging or nutritional treatment (T4 lymphocytes:
adults T0: 0.98 ± 0.09, T1: 0.87 ± 0.06; elderly T0:0 . 6 1±
0.05, T1: 0.89 ± 0.20) (T8 lymphocytes: adults T0:0 . 5 8±
0.05, T1: 0.48 ± 0.04; elderly T0: 0.38 ± 0.05, T1:0 . 5 8±
0.20). Thus, the ratio of CD4
+ to CD8
+ cells was stable
(adults T0: 1.78 ± 0.12, T1: 1.95 ± 0.14; elderly T0:
1.93 ± 0.24, T1: 2.11 ± 0.30).
Distribution between naive (CD4-CD45RA
+)a n d
memory (CD4-CD45RO
+) T4 cells was modified by
aging (table 4). Percentages (in %) and absolute values
(in 10
9/L) of CD4-CD45RA
+ cells were higher in young
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CD45RO
+ cells was lower in young adults than older
subjects. Retinoic acid supplementation induced no
alteration in distribution between CD4-CD45RA
+ and
CD4-CD45RO
+ cells (table 4).
Proportions of HLA-DR
+ cells or CD69
+ cells were
not affected by aging or retinoic acid supplementation
(HLA DR
+ cells: young adults, T0: 12.9 ± 0.9% vs T1:
14.3 ± 0.86%; elderly subjects, T0: 14.2 ± 0.8% vs T1:
16.3 ± 0.9%; CD69
+ cells: young adults: T0: 0.60 ± 0.06%
vs T1: 0.49 ± 0.04%; elderly subjects: T0: 0.64 ± 0.11% vs
T1: 0.71 ± 0.14%). The same pattern was found for the
absolute counts of the two populations (data not
shown).
PMN cells
Proportions of cells expressing CD11b, CD18, CD62L (in
%) were not statistically different between young adults
(99.9 ± 0.1, 99.8 ± 0.1, 84.1 ± 3.1 respectively) and older
subjects (99.9 ± 0.1, 99.8 ± 0.2, 84.0 ± 3.1 respectively) and
were not altered by retinoic acid supplementation (T0:
99.9 ± 0.1, 99.8 ± 0.1, 83.3 ± 2.9 vs T1: 99.9 ± 0.1, 99.9 ±
0.1, 83.8 ± 3.3, respectively). The same pattern was found
for absolute numbers of cells expressing CD11b, CD18
and CD62 (data not shown). Concerning the fluorescence
intensity of CD11b, since we found no significant interac-
tion (p = 0.296), comparison of marginal means was car-
ried out, which indicated a significant effect of nutritional
treatment (T0: 10.3 ± 1.1 vs T1: 13.5 ± 1.2, p = 0.048) and
no effect of aging (young adults: 13.4 ± 1.3 vs elderly sub-
jects: 10.4 ± 0.9, p = 0.063).
Blood leukocyte functions
Peripheral blood mononuclear cells
Il-2 production, sIl-2R production, and membrane
expression of Il-2 receptor chain (% of CD25) were not
significantly different between young adults and older
subjects, and were not affected by retinoic acid supple-
mentation (Table 5). Number of CD25 receptors per
cell was lower in young adults than old subjects only in
cells incubated for 96 h with PHA, and was not altered
by retinoic acid supplementation (Table 5).
Polymorphonuclear cells
Chemotaxis index was not modified by aging but was
decreased by retinoic acid supplementation due to an
increase in spontaneous migration (Figure 1).
Hydrogen peroxide production (expressed in AU) by
PMN suspension stimulated with PMA, a marker of
bactericidal activity, was modified neither by aging
(adults: 124 ± 10 vs elderly: 128 ± 13) nor by retinoic
acid supplementation (T0: 119 ± 7 vs T1: 133 ± 15). The
same result was obtained for phagocytosis, with H2O2
production (in AU) by PMN suspension stimulated with
zymosan: young adults: 3.26 ± 0.16 vs elderly subjects:
3.23 ± 0.17; T0 3.42 ± 0.17 vs T1 3.03 ± 0.16.
Table 2 Plasma retinoic acid and retinol concentrations at basal state (T0) and after supplementation with
13-cis-retinoic acid (T1)
Young adults Elderly ANOVA
T0 T1 T0 T1
13-cis-retinoic acid (mg/l) 1.30 ± 0.08 202.61 ± 20 1.43 ± 0.07 149.95 ± 8.7 A, N, I
Retinol (μM) 2.76 ± 0.11 2.53 ± 0.09 3.14 ± 0.13 3.12 ± 0.15 A
X ± SEM; n = 20 subjects per group. Two-way repeated-measures ANOVA was performed to discriminate among the effects of age (A; p < 0.05), nutritional
treatment (N; p < 0.05) and their interaction (I; p < 0.05).
For retinol, no significant interaction was found, and so comparison of marginal means was carried out, which indicated a significant effect of age (young: 2.64 ±
0.07 μM vs elderly: 3.13 ± 0.09 μM).
Table 3 Lymphocyte distribution at basal state (T0) and
after supplementation with 13-cis-retinoic acid (T1)
Young adults Elderly
T0 T1 T0 T1 ANOVA
T Lymphocytes ±
10
9/L 1.56 ±
0.14
1.35 ±
0.09
0.99 ±
0.09
1.47 ±
0.45
-
% 68.1 ±
1.6
69.2 ±
1.3
64.7 ±
2.1
67.4 ±
1.7
-
B Lymphocytes
10
9/L 0.29 ±
0.04
0.26 ±
0.03
0.16 ±
0.02
0.22 ±
0.04
A
% 11.9 ±
0.9
12.6 ±
1.0
9.9 ± 0.8 11.2 ±
0.9
-
NK
Lymphocytes
10
9/L 0.48 ±
0.06
0.33 ±
0.04
0.34 ±
0.04
0.38 ±
0.06
-
% 18.9 ±
1.8
15.8 ±
1.5
23.1 ± 22 21.0 ±
1.8
A
X ± SEM; n = 20 subjects per group. Lymphocytes are expressed both as
percentages of the total lymphocyte number and as absolute values. Two-way
repeated-measures ANOVA was performed to discriminate among the effects
of age (A; p < 0.05), nutritional treatment (N; p < 0.05) and their interaction (I;
p < 0.05).
As no significant interaction was found, comparison of marginal means was
carried out, which indicated a significant effect of age on the absolute
number (in 10
9/L) of B lymphocytes (young: 0.276 ± 0.032 vs elderly: 0.186 ±
0.032) and on percentage of NK lymphocytes (young: 17.35 ± 1.69 vs elderly:
22.08 ± 1.97).
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An age-associated decline in immune function is well
documented [54], yet the mechanisms involved are
unclear, and it is becoming increasingly important to
gain a deeper understanding of this dysfunction as aver-
age life expectancies reach record levels. Nutritional fac-
tors such as vitamin A may be implicated, since
retinoids modulate different parts of the immune
response components in both innate and adaptive
immunity. While there is a significant body of research
on the cellular and molecular mechanisms underlying
these effects [55,56], most of these studies are either
animal studies or in vitro studies on isolated immune
cells. However, the complexity of nuclear retinoid recep-
tors, their ligands and the various response elements in
around a hundred genes makes it difficult to extrapolate
results drawn from animal studies to in vivo human
contexts. The present study brings original contribu-
tions, i) as it was performed in healthy humans and in
both young and elderly groups, and ii) it investigates the
immunomodulatory properties of retinoids directly
through the active metabolite of vitamin A, which allow
us to focus on alterations in vitamin A metabolism dur-
i n ga g i n g .W eh a v ep r e v i o u s l yd e m o n s t r a t e dad o w n r e -
gulated RXRb expression in PBMCs isolated from
healthy elderly subjects [39,40] and upregulated RXRb
expression after oral supplementation with 13-cis reti-
noic acid [40]. In order to better understand the role of
retinoic acid in immunosenescence, we investigated the
immune impact of these modified retinoic acid receptors
by performing phenotype and functional assessment of
blood leukocytes.
Comparison between young adult and older healthy
subjects
In our selected old population, alterations in immune
capacity translated as a greater proportion of NK cells, a
decrease in B lymphocytes and stable number of T-cells.
A possible explanation for this result is a decline in T-
cell turnover in the periphery of aged subjects with a
decrease in T-cell generation and an increase in periph-
eral T-cell longevity [1]. In this T-cell population, we
observed a decline in the proportion of naive T4 lym-
phocytes in parallel with an increase in memory T4
Table 4 Naïve and memory T4 lymphocyte distribution at basal state (T0) and after supplementation with
13-cis-retinoic acid (T1)
Young adults Elderly
T0 T1 T0 T1 ANOVA
CD4-CD45RO+
% 31.2 ± 1.74 29.36 ± 1.26 34.24 ± 1.81 35.88 ± 1.88 A
10
9/L 0.751 ± 0.074 0.582 ± 0.052 0.527 ± 0.042 0.785 ± O.235 -
CD4-CD45RA+
% 25.87 ± 1.70 24.32 ± 1.35 13.80 ± 1.92 15.18 ± 1.633 A
10
9/L 0.620 ± 0.064 0.468 ± 0.222 0.219 ± 0.036 0.309 ± 0.078 A
X ± SEM; n = 20 subjects per group. Lymphocytes are expressed both as percentages of lymphocyte number and as absolute values. Two-way repeated-
measures ANOVA was performed to discriminate among the effects of age (A; p < 0.05), nutritional treatment (N; p < 0.05) and their interaction (I; p < 0.05).
As no significant interaction was found, comparison of marginal means was carried out, which indicated a significant effect of age on the absolute number (in
10
9/L) of CD4-CD45RA (young: 0.54 ± 0.04 vs elderly: 0.26 ± 0.04) and on percentage of CD4-CD45RA (young: 24.9 ± 1.1 vs elderly: 14.5 ± 1.3) and CD4-CD45RO
(young: 30.5 ± 1.1: vs elderly: 35.1 ± 1.3).
Table 5 Blood mononuclear cell functions at basal state (T0) and after supplementation with 13-cis-retinoic acid (T1)
Parameters Incubation Young adults Elderly
Time T0 T1 T0 T1 ANOVA
IL2 production 48 h 0.57 ± 0.24 0.75 ± 0.22 1.95 ± 0.75 0.77 ± 0.18 -
sIl-2R production 48 h 168 ± 24 186 ± 25 174 ± 27 201 ± 28 -
Membrane expression of CD25 (%) 48 h 27.5 ± 3.7 27.1 ± 2.8 21.3 ± 2.9 20.9 ± 2.4 -
96 h 28 ± 2.9 34.4 ± 3.1 32.7 ± 3.9 32.4 ± 3.9 -
Number of CD25 receptors per cell 48 h 1214 ± 51 1366 ± 75 1157 ± 46 1262 ± 68 -
96 h 874 ± 12 952 ± 22 1064 ± 67 1089 ± 27 A
X ± SEM; n = 20 subjects per group. Two-way repeated-measures ANOVA was performed to discriminate among the effects of age (A; p < 0.05), nutritional
treatment (N; p < 0.05) and their interaction (I; p < 0.05).
Il-2 and sIl-2R productions were determined in culture media and expressed in fmol/10
6 cells
As no significant interaction was found, comparison of marginal means was carried out, which indicated a significant effect of age on number of CD25 receptors
per cell (96 h) (young: 914.03 ± 14.16 vs elderly: 1077.24 ± 34.21)
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Page 6 of 11lymphocytes. This shift from a predominantly naive phe-
notype in the young to a predominantly memory pheno-
type in the aged subjects may explain the altered T-cell
response widely reported in aged subjects.
T h i sd e f e c tm a yb ed u en o to n l yt ot h eh i g ha g eo f
T-cells [57] but also to age-related differences in the
lymphoid microenvironment [58], with a drop in con-
centration of IL7 cells which increase the lifespan of
naïve CD4T cells and/or to intrinsic defects in aged
T-cells [59,60].
Effect of retinoic acid supplementation
Even if the dose of retinoic acid used was the same in
the two populations studied, plasma retinoic acid con-
centrations were slightly lower in older subjects. This
difference may not be explained by a difference in nutri-
tional intake. Indeed, dietary intakes data did not show
a decrease but an increase in a and b carotene intakes
in older subjects compared with young adults. In addi-
tion, the bioavailability of these carotenoids with provi-
tamin A activity is the same between young and older
subjects [61]. This prompts us to suggest that retinoic
acid metabolism is somewhat different between these
two populations.
Lymphocyte phenotypes
In this in vivo human study, retinoic acid induced no
modification in lymphocyte subsets in the two popula-
tions considered.
In adults, these results are consistent with the data of
McKerrow et al. [62] but slightly different from those of
Prabhala et al. and Watson et al. Employing in vitro [63]
and in vivo [64] approaches, these authors showed that
retinoic acid increased the percentage of both T-helper
cells and NK cells and slightly decreased the percentage
of T-suppressor cells.
In older subjects, Prabhala et al. [65] suggested that
retinoic acid consumption may have a moderate
immunoenhancing effect due to a significant increase
in T4 and B cells. Fortes [66] reported similar results
in an elderly population after 3 months of supplemen-
tation with vitamin A and zinc. The discrepancies
between these reports may result from the duration of
the study and the expression mode of the cell
population.
As regards lymphocyte activation markers (CD25,
CD69, HLA-DR), we report no effect of retinoic acid
supplementation on these parameters in either young
adult or old subjects.
Mononuclear cell functions
Il-2 production was not modified by retinoic acid sup-
plementation in either young adult or older subjects.
T h i sr e s u l tm a yb ee x p l a i n e db yan e g a t i v er e t i n o i ca c i d
regulation on PHA-induced immune cell activation [67].
It is likely that retinoic acid reduces the protein produc-
tion and gene expression of the Il-2 upregulated by
PHA. This process is mediated through negative actions
on c-fos and c-jun gene expression which would lead to
the repression of the activity of AP-1, which interacts
with the Il-2 promoter [67]. In addition, we observed a
broad variability in Il-2 production which, as suggested
by Engedal [55], may be explained by inter-blood donor
variability in the strength of the anti-apoptotic effect of
retinoic acid in T cells. The literature highlights major
disparity in the effect of retinoic acid on Il-2 secretion,
which may be explained by the differences in the
immune system in the species studies. Retinoic acid
inhibits in vivo interleukin-2 gene expression and T-cell
activation in mice [68].
Serum immune parameters
Retinoic acid supplementation in vivo did not induce
significant changes in immunoglobulin serum concen-
trations. The specific effect of all-trans-retinoic acid on
immunoglobulin synthesis by B-lymphocytes has also
been extensively reviewed by Semba et al. [33] and
Ertesvag et al. [68]. They concluded that the conflicting
results were probably attributable to differences in the
experimental conditions and/or the origin of the
immune cell. Some studies suggest that retinoic acid
treatment of B cells could reduce immunoglobulin
secretion, while others have demonstrated that retinoic
acid may potentiate antibody-mediated immunity
[32,69].
Figure 1 Neutrophils chemotaxis. Cell migration distances (in
mm) are measured microscopically in the direction of the
chemoattractant (directed migration (DM)) and towards the control
(spontaneous migration (SM)). Neutrophils chemotaxis index is
expressed as the ratio of directed to spontaneous migration of PMN
cells. x ± SEM; n = 20 subjects per group. Two-way repeated-
measures ANOVA was performed to discriminate among the effects
of age (A; p < 0.05), nutritional treatment (N; p < 0.05) and their
interaction (I; p < 0.05). There was a significant effect of nutritional
treatment for both chemotaxis index and spontaneous migration.
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T-helper type 1 and T-helper type 2 response [70-73].
RXR signaling may play an important role in this Th-
cell differentiation [74]. Indeed, RXR pathways enhance
Th2 development in Ag-naive Th0 cells from DO11.10
TCR-transgenic mice [71]. Vitamin A enhances in vitro
Th2 development via retinoid × receptor pathway
whereas disruption of RXRa produced a Th1 bias
in vivo [75]. Our finding that retinoic acid supplementa-
tion induced no increase in Il-2 production and no
modification in immunoglobulin levels suggest no shift
from Th1 to Th2 immune response in old subjects.
Consequently, since we have previously shown that
RXRb expression is upregulated in old healthy subjects
supplemented with 13-cis retinoic acid [40], these data
may corroborate results from Iwata et al. [72] suggesting
that RAR are also involved in the direct effect of RA on
Th1/Th2 development.
PMN phenotypes and functions
PMN provide the first line of defense against infection.
These cells play a pivotal role in the innate immune
response and are the first to respond and target bacteria,
fungi, protozoa and viruses. Briefly, the PMN cells
adhere to the endothelium, chemotax towards the target
organism or cell, phagocyte it and then use an arsenal
of enzymes and active oxygen species to kill their target.
Focusing on transendothelial migration, PMN rolling on
activated endothelium and the adherence of PMN to the
activated endothelium are critical steps. L-selectin
(CD62l), which is a transmembrane glycoprotein, is an
adhesion molecule on the PMN surface that promotes
rolling adhesion. Firm adherence and diapedesis are
mediated by b2 integrins, CD11b/CD18. Effect of reti-
n o i d so nP M Nf u n c t i o n sh a sb e e nw e l ls t u d i e di na n i -
mals. Functional studies performed in vitamin A-
deficient animals show defects in chemotaxis, adhesion,
phagocytosis, and reactive species production in neutro-
phils whereas vitamin A supplementation reverses these
defects [76]. It has also been demonstrated that retinoids
(retinol, retinoic acid, all-trans-retinal) stimulate super-
oxide production in vitro by guinea pig PMN [77-79], in
vitro phagocytosis [80,81] bis dairy calves) and intracel-
lular kill of live Staphylococcus aureus by blood PMN
[82]. However, there is only limited research on the spe-
cific effect of vitamin A on neutrophil functions in
humans, and the data produced came either from obser-
vation of malnourished subjects or from studies of vita-
min A supplementation. In the first case, it is difficult to
assess the specific effects of vitamin A since malnutri-
tion is associated with multiple micronutrient deficiency.
In the second case, the supplementation studies focused
on specific groups, i.e. pregnant women and children,
and the results are not consistent (for review, see [35]).
In the present study performed on adult and elderly
healthy subjects, we demonstrate that retinoids had a
marked effect on two PMN functions, i.e. adhesion
(increase in fluorescence intensity of a b2i n t e g r i n
CD11b) and chemotaxis. The molecular pathways
underpinning these effects have not yet been clearly
established (for review, see [83]) but the Raf-1/MEK/Erk
pathway [84,85] and intracellular adaptor molecules, i.e.
PML-retinoic acid receptor alpha (RARa)-regulated
adaptor molecule 1 (PRAM-1) [86] have been identified
as essential for the integrin signaling cascade in neutro-
phils. Otherwise, b2 integrin (CD11b)-mediated adhe-
sion of human polymorphonuclear neutrophils (PMN)
has a functional impact on cytokine (Il8) production
[87]. Therefore, our study inh u m a n sc o n f i r m ss o m eo f
the properties of retinoids on innate immunity pre-
viously demonstrated in animals, and contributes insight
into the specific effect of retinoids on neutrophil func-
tions during aging.
Conclusions
We investigated the immunomodulatory properties of
retinoic acid by employing a human in vivo approach
rather than the experimental or animal study
approaches reported to date. In addition, this is the first
study performed in both young and old healthy popula-
tions to directly use the active metabolite of vitamin A,
i.e. retinoic acid, and to measure plasma retinoid con-
centrations concomitantly with an evaluation of immune
response. We elected to use the same dose of retinoic
acid in the two populations, and we have demonstrated
that immune response to retinoids was the same
between adult and elderly subjects, despite lower plasma
retinoic acid concentrations in the elderly subjects. Con-
sequently, these results may suggest i) that retinoid
metabolism evolves during aging, and ii) that sensitivity
of immune cells is probably higher in old populations.
To assess this second hypothesis, it would be interesting
to run an in vitro experiment investigating the retinoid
dose-response of immune cells isolated from adult and
elderly donors. Among the immune cells studied, the
effects of retinoids are more pronounced on PMN that
PBMC. Indeed, while retinoic acid supplementation
upregulates PBMC RXRb expression in elderly subjects
up to the levels found in young adults, this modification
is without effect on PBMC phenotype and functions.
Concerning PMN, we show that retinoic acid stimulates
neutrophils adhesion and migration functions in the two
aged populations via a process mediated by an increase
in the b2 integrin CD11b expression. According to these
results, retinoids may promote immune response in
healthy adults and elderly by improving PMNs defense
functions in terms of adhesion and chemotaxis. The
nuclear pathway underpinning this effect remains to be
explored. There is still limited data on the effects of
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aging, and published results remain elusive. Our study
adds a new facet to the understanding on this topic.
However, further research is required to confirm the
importance of retinoids in the immune system and espe-
cially in PMN functions in elderly subjects. In addition,
considering that older subjects fail to elicit full immune
response to viral and bacterial pathogens, and given the
central role played by PMN in tissue injury during infec-
tion and the role of retinoids on PMN functions,
research should be usefully directed towards investigat-
ing the effects of retinoic acid supplementation on
immune response in elderly infected subjects.
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